In 2025, Gavi-supported immunization programs delivered over $30 billion in economic benefits to lower-income countries, reducing healthcare costs and boosting productivity. Countries invested a record $301 million in co-financing these vaccines, demonstrating their commitment to public health. Dr. Sania Nishtar, Gavi CEO, highlighted the significant return on investment, emphasizing the role of immunization in fostering sustainable economic growth.

Originally reported by AllAfrica